Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018 - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Cytotherapy Année : 2018

Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018

1 Department of Orthopedic Surgery [Cleveland, Ohio, USA]
2 Instituto Universitario del Hospital Italiano [Buenos Aires, Argentina]
3 Laboratory of Cellular Therapy - Department of Medical and Surgical Sciences for Children and Adults [Modena, Italy]
4 MTF Biologics, Edison [New Jersey, USA]
5 School of Medicine - Adult Reconstruction-Adolescent and Young Adult Hip Service [St. Louis, Missouri, USA]
6 Orthopaedic Soft Tissue Research Program [New York, NY, USA]
7 Department of Orthopaedic Surgery [Houston, TX, USA]
8 Steadman Philippon Research Institute
9 RMeS - Regenerative Medicine and Skeleton
10 Pôle hospitalo-universitaire PHU4 - OTONN - Ostéo-articulaire - Tête et cou - Odontologie - Neurochirurgie - Neurotraumatologie [CHU Nantes]
11 Advanced Regenerative Manufacturing Institute [Manchester, NH, USA]
12 Standards Coordinating Body
13 Orthopaedic Research Center - Department of Clinical Sciences [Fort Collins, CO, USA]
14 Vetbiobank [Marcy l’Etoile, France]
15 Skeletal Biology Section - Department of Health and Human Services [Bethesda, MD, USA]
16 Department of Pathology and Laboratory Medicine [New-York, NY, USA]
17 Stem Cell Allogeneic Transplant Section [Bethesda, MD, USA]
18 Regenerative Medicine Institute [Galway, Ireland]
19 Greyledge Technologies - LLC [Vail, CO, USA]
20 Department of Orthopaedic Surgery [Stanford]
21 Veterans Affairs Palo Alto Health Care System [Palo Alto, CA, USA]
22 University of Vermont [Burlington]
23 Department of Biomedicine [Basel]
24 Unité thérapeutique d'immunologie clinique et des maladies ostéoarticulaires [Hôpital Lapeyronie, Montpellier]
Daniel Weiss
  • Fonction : Auteur
  • PersonId : 890004

Résumé

The Signature Series Symposium "Cellular Therapies for Orthopaedics and Musculoskeletal Disease Proven and Unproven Therapies-Promise, Facts and Fantasy" was held as a pre-meeting of the 26th International Society for Cellular Therapy (ISCT) annual congress in Montreal, Canada, May 2, 2018. This was the first ISCT program that was entirely dedicated to the advancement of cell-based therapies for musculoskeletal diseases. Cellular therapies in musculoskeletal medicine are a source of great promise and opportunity. They are also the source of public controversy, confusion and misinformation. Patients, clinicians, scientists, industry and government share a commitment to clear communication and responsible development of the field. Therefore, this symposium convened thought leaders from around the world in a forum designed to catalyze communication and collaboration to bring the greatest possible innovation and value to patients with musculoskeletal conditions.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-01896319 , version 1 (16-10-2018)

Identifiants

Citer

Nicolas Piuzzi, Massimo Dominici, Marc Long, Cecilia Pascual-Garrido, Scott Rodeo, et al.. Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018. Cytotherapy, 2018, Epub ahead of print. ⟨10.1016/j.jcyt.2018.09.001⟩. ⟨inserm-01896319⟩
73 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More